
Cullinan Management CGEM
€ 8.21
-2.8%
Land |
|
IPO-Jahr |
2021 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
60.2 M |
Marktkapitalisierung |
$ 543 M |
EBITDA (LTM) |
$ -219 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
INmune Bio
INMB
|
$ 1.02 | 6.25 % | $ 25.3 M | Nasdaq Capital Market | ||
|
Ionis Pharmaceuticals
IONS
|
$ 27.39 | 1.59 % | $ 4.38 B | Nasdaq Global Select Market,SPB | ||
|
Jazz Pharmaceuticals plc
JAZZ
|
$ 246.57 | 2.43 % | $ 15 B | Nasdaq Global Select Market | ||
|
Nektar Therapeutics
NKTR
|
$ 34.77 | -3.17 % | $ 587 M | Nasdaq Global Select Market,SPB | ||
|
Kala Pharmaceuticals
KALA
|
$ 3.31 | -3.5 % | $ 27 M | Nasdaq Global Select Market | ||
|
Novartis AG
NVS
|
$ 155.26 | -2.43 % | $ 301 B | NYSE | ||
|
Omeros Corporation
OMER
|
$ 14.67 | 4.24 % | $ 932 M | Nasdaq Global Select Market | ||
|
Lineage Cell Therapeutics
LCTX
|
$ 0.84 | 3.54 % | $ 193 M | NYSE American | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
$ 298.84 | 1.71 % | $ 5.78 B | Nasdaq Global Select Market,SPB | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
$ 1.2 | 4.35 % | $ 54.8 M | Nasdaq Capital Market | ||
|
Mustang Bio
MBIO
|
$ 0.38 | -2.31 % | $ 1.87 M | Nasdaq Global Market | ||
|
Adagene
ADAG
|
$ 1.78 | 20.27 % | $ 105 M | Nasdaq Global Market | ||
|
Puma Biotechnology
PBYI
|
$ 7.22 | 1.12 % | $ 361 M | Nasdaq Global Select Market | ||
|
Denali Therapeutics
DNLI
|
$ 18.41 | 2.25 % | $ 3.18 B | Nasdaq Global Select Market,SPB | ||
|
Amarin Corporation plc
AMRN
|
$ 11.25 | -0.18 % | $ 4.67 B | Nasdaq Global Market | ||
|
ImmuCell Corporation
ICCC
|
$ 11.2 | -1.15 % | $ 101 M | Nasdaq Global Select Market | ||
|
Editas Medicine
EDIT
|
$ 1.77 | -3.29 % | $ 157 M | Nasdaq Global Select Market,SPB | ||
|
Agios Pharmaceuticals
AGIO
|
$ 29.7 | -0.64 % | $ 1.72 B | Nasdaq Global Select Market,SPB | ||
|
Pfizer
PFE
|
$ 28.06 | -1.46 % | $ 159 B | NYSE,SPB | ||
|
NuCana plc
NCNA
|
$ 0.82 | -7.71 % | $ 9.21 B | Nasdaq Global Select Market | ||
|
Equillium
EQ
|
$ 1.1 | -9.5 % | $ 63 M | Nasdaq Global Market | ||
|
Black Diamond Therapeutics
BDTX
|
$ 1.43 | -1.04 % | $ 81.3 M | Nasdaq Global Select Market,SPB | ||
|
Abeona Therapeutics
ABEO
|
$ 2.73 | 4.81 % | $ 145 M | Nasdaq Capital Market | ||
|
ACADIA Pharmaceuticals
ACAD
|
$ 18.0 | -1.77 % | $ 3.03 B | Nasdaq Global Select Market,SPB | ||
|
Atossa Therapeutics
ATOS
|
$ 1.8 | -5.26 % | $ 15.5 M | Nasdaq Capital Market | ||
|
Cleveland BioLabs, Inc.
CBLI
|
- | -7.31 % | $ 49 M | Nasdaq Capital Market | ||
|
Pliant Therapeutics
PLRX
|
$ 0.66 | 0.38 % | $ 40.5 M | Nasdaq Global Select Market | ||
|
Five Prime Therapeutics, Inc.
FPRX
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
ADC Therapeutics SA
ADCT
|
$ 1.33 | -1.48 % | $ 169 M | NYSE | ||
|
Harmony Biosciences Holdings
HRMY
|
$ 33.1 | 0.29 % | $ 1.9 B | Nasdaq Global Select Market | ||
|
Ardelyx
ARDX
|
$ 3.15 | -1.1 % | $ 759 M | Nasdaq Global Market | ||
|
Akebia Therapeutics
AKBA
|
$ 0.41 | 2.22 % | $ 105 M | Nasdaq Global Market | ||
|
Alector
ALEC
|
$ 2.56 | 1.17 % | $ 264 M | Nasdaq Global Select Market,SPB | ||
|
ALX Oncology Holdings
ALXO
|
$ 0.97 | -3.11 % | $ 52 M | Nasdaq Global Select Market,SPB | ||
|
Amneal Pharmaceuticals
AMRX
|
$ 21.81 | 3.27 % | $ 6.83 B | NYSE | ||
|
Arbutus Biopharma Corporation
ABUS
|
$ 4.12 | 1.6 % | $ 789 M | Nasdaq Global Select Market | ||
|
Agenus
AGEN
|
$ 6.39 | 2.82 % | $ 190 M | Nasdaq Capital Market | ||
|
PolyPid Ltd.
PYPD
|
$ 6.52 | -0.31 % | $ 107 M | Nasdaq Global Select Market | ||
|
AbCellera Biologics
ABCL
|
$ 11.0 | -0.32 % | $ 3.29 B | Nasdaq Global Select Market | ||
|
Artelo Biosciences
ARTL
|
$ 1.5 | -10.71 % | $ 284 K | Nasdaq Global Select Market | ||
|
Immatics N.V.
IMTX
|
$ 6.11 | -2.94 % | $ 748 M | Nasdaq Global Select Market | ||
|
Aptevo Therapeutics
APVO
|
$ 0.45 | -3.45 % | $ 142 K | Nasdaq Capital Market | ||
|
Aligos Therapeutics
ALGS
|
$ 1.3 | -4.41 % | $ 12.9 M | Nasdaq Global Select Market | ||
|
Aclaris Therapeutics
ACRS
|
$ 3.48 | 2.81 % | $ 427 M | Nasdaq Global Select Market | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
$ 28.47 | -0.07 % | $ 4.32 B | Nasdaq Global Select Market,SPB | ||
|
Cellectar Biosciences
CLRB
|
$ 0.89 | -3.51 % | $ 2.32 M | Nasdaq Capital Market | ||
|
Larimar Therapeutics
LRMR
|
$ 3.22 | 7.69 % | $ 268 M | Nasdaq Global Market | ||
|
Biofrontera AG
BFRA
|
- | -8.24 % | $ 105 M | Nasdaq Capital Market | ||
|
Pulmatrix
PULM
|
$ 1.34 | -2.19 % | $ 4.89 B | Nasdaq Global Select Market | ||
|
Intellia Therapeutics
NTLA
|
$ 9.68 | -1.07 % | $ 1.05 B | Nasdaq Global Market,SPB |